Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 5
2005 3
2006 4
2007 3
2008 6
2009 7
2010 5
2011 12
2012 10
2013 9
2014 14
2015 7
2016 22
2017 26
2018 14
2019 10
2020 21
2021 24
2022 24
2023 15
2024 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

230 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Carbohydrate-Restricted Diets and Intermittent Fasting on Obesity, Type 2 Diabetes Mellitus, and Hypertension Management: Consensus Statement of the Korean Society for the Study of Obesity, Korean Diabetes Association, and Korean Society of Hypertension.
Choi JH, Cho YJ, Kim HJ, Ko SH, Chon S, Kang JH, Kim KK, Kim EM, Kim HJ, Song KH, Nam GE, Kim KI; Committee of Clinical Practice Guidelines; Korean Society for the Study of Obesity (KSSO); Committee of Clinical Practice Guidelines and Committee of Food and Nutrition, Korean Diabetes Association (KDA); Policy Committee of Korean Society of Hypertension (KSH); Policy Development Committee of National Academy of Medicine of Korea (NAMOK). Choi JH, et al. Among authors: ko sh. Diabetes Metab J. 2022 May;46(3):355-376. doi: 10.4093/dmj.2022.0038. Epub 2022 May 25. Diabetes Metab J. 2022. PMID: 35656560 Free PMC article. Review.
The Efficacy and Safety of Moderate-Intensity Rosuvastatin with Ezetimibe versus High-Intensity Rosuvastatin in High Atherosclerotic Cardiovascular Disease Risk Patients with Type 2 Diabetes Mellitus: A Randomized, Multicenter, Open, Parallel, Phase 4 Study.
Moon JS, Park IR, Kim SS, Kim HS, Kim NH, Kim SG, Ko SH, Lee JH, Lee I, Lee BK, Won KC. Moon JS, et al. Among authors: ko sh. Diabetes Metab J. 2023 Nov;47(6):818-825. doi: 10.4093/dmj.2023.0171. Epub 2023 Nov 24. Diabetes Metab J. 2023. PMID: 38043782 Free PMC article. Clinical Trial.
Clinical Guidelines for the Management of Adrenal Incidentaloma.
Lee JM, Kim MK, Ko SH, Koh JM, Kim BY, Kim SW, Kim SK, Kim HJ, Ryu OH, Park J, Lim JS, Kim SY, Shong YK, Yoo SJ; Korean Endocrine Society, Committee for Clinical Practice Guidelines. Lee JM, et al. Among authors: ko sh. Endocrinol Metab (Seoul). 2017 Jun;32(2):200-218. doi: 10.3803/EnM.2017.32.2.200. Endocrinol Metab (Seoul). 2017. PMID: 28685511 Free PMC article. Review.
Monotherapy in patients with type 2 diabetes mellitus.
Rhee SY, Kim HJ, Ko SH, Hur KY, Kim NH, Moon MK, Park SO, Lee BW, Choi KM, Kim JH; Committee of Clinical Practice Guideline of Korean Diabetes Association. Rhee SY, et al. Among authors: ko sh. Korean J Intern Med. 2017 Nov;32(6):959-966. doi: 10.3904/kjim.2017.312. Epub 2017 Oct 23. Korean J Intern Med. 2017. PMID: 29057643 Free PMC article. Review.
Monotherapy in Patients with Type 2 Diabetes Mellitus.
Rhee SY, Kim HJ, Ko SH, Hur KY, Kim NH, Moon MK, Park SO, Lee BW, Choi KM, Kim JH; Committee of Clinical Practice Guideline of Korean Diabetes Association. Rhee SY, et al. Among authors: ko sh. Diabetes Metab J. 2017 Oct;41(5):349-356. doi: 10.4093/dmj.2017.41.5.349. Diabetes Metab J. 2017. PMID: 29086532 Free PMC article. Review.
Diabetes Fact Sheet in Korea 2021.
Bae JH, Han KD, Ko SH, Yang YS, Choi JH, Choi KM, Kwon HS, Won KC. Bae JH, et al. Among authors: ko sh. Diabetes Metab J. 2022 May;46(3):417-426. doi: 10.4093/dmj.2022.0106. Epub 2022 May 25. Diabetes Metab J. 2022. PMID: 35656565 Free PMC article.
A Multicenter, Randomized, Open-Label Study to Compare the Effects of Gemigliptin Add-on or Escalation of Metformin Dose on Glycemic Control and Safety in Patients with Inadequately Controlled Type 2 Diabetes Mellitus Treated with Metformin and SGLT-2 Inhibitors (SO GOOD Study).
Kim HJ, Noh JH, Moon MK, Choi SH, Ko SH, Rhee EJ, Hur KY, Jeong IK. Kim HJ, et al. Among authors: ko sh. J Diabetes Res. 2024 Jan 5;2024:8915591. doi: 10.1155/2024/8915591. eCollection 2024. J Diabetes Res. 2024. PMID: 38223523 Free PMC article. Clinical Trial.
230 results